NewslettersImmune Regulation News Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages By lbeveridge - September 20, 2022 0 Researchers showed that the therapeutic efficacy of αCD40 in subcutaneous melanoma relies on pre-existing, type 1 classical dendritic cell-primed CD8+ T cells. [Cancer Research] Abstract